ProBioGen AG
Goethestr. 54
Berlin
13086
Germany
Tel: 49-30-9-24-00-60
Fax: 49-30-924006-19
Website: http://www.probiogen.de/
Email: info@probiogen.de
69 articles about ProBioGen AG
-
Ryvu and Opthea have new funding to work with, Tessa Therapeutics and Enlivex kick off new trials and Revive Therapeutics amends the Phase III protocol for its COVID-19 hopeful.
-
Biopharma and life sciences companies from across the globe provide updates to their pipelines and businesses.
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Global biopharma and life sciences companies provide updates to their businesses and pipelines.
-
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations including Takeda, Origin Therapeutics, ERS Genomics and more.
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Global Roundup: UK Expands Life Sciences Ecosystem with Formation of We Are Pioneering Group
4/29/2021
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines. -
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
BioSpace Global Roundup, Oct. 29
10/29/2020
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines. -
ProBioGen AG Appoints Dr. Lutz Hilbrich as New Chief Executive Officer - Dr. Wieland Wolf Retires
4/28/2020
ProBioGen AG, a premier, Berlin-based CDMO for developing and manufacturing complex therapeutic glycoproteins today announced that Dr. Lutz Hilbrich, an experienced biotech executive, has been named Chief Executive Officer, effective June 1, 2020
-
BioSpace Global Roundup, March 26
3/26/2020
Pharma and life sciences companies from across the globe provide updates on their pipelines and business practices. -
BioSpace Global Roundup, Feb. 27
2/27/2020
Biopharma and life sciences companies from across the globe provide updates on their pipelines and business operations. -
BioSpace Global Roundup, Jan. 16
1/16/2020
Companies from across the globe provide updates to their business and pipeline. -
ProBioGen and Lava Therapeutics Sign Cell Line Development and GMP Manufacturing Agreement for Novel Bispecific Molecule
1/14/2020
ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate..
-
BioSpace Global Roundup, Jan. 9
1/9/2020
Pharma and biotech companies from across the globe provide business and pipeline updates. -
ProBioGen Inks Next Commercial GlymaxX® License with Roche
1/8/2020
ProBioGen AG has signed a commercial license agreement with Roche for applying ProBioGen’s proprietary GlymaxX® technology to boost the antibody’s ADCC anti-tumor activity.
-
BioSpace Global Roundup, Nov. 14
11/14/2019
Companies from across the globe provide updates on their business and pipelines.